Calidi Biotherapeutics (CLDI) Change in Cash (2022 - 2025)

Calidi Biotherapeutics' Change in Cash history runs 4 years deep, the most recent figure standing at -$4.8 million for Q4 2025.

• In Q4 2025, Change in Cash fell 162.06% year-over-year to -$4.8 million; the TTM figure through Dec 2025 stood at -$4.0 million (down 152.21% YoY), while the FY2025 annual figure was -$4.0 million, down 152.21% from the prior year.
• Change in Cash for Q4 2025 stood at -$4.8 million, down from $5.2 million in the prior quarter.
• The five-year high for Change in Cash was $8.1 million in Q3 2023, with the low at -$8.2 million in Q4 2023.
• The 4-year median for Change in Cash is $10660.5 (2022), against an average of $223875.0.
• Peak annual rise in Change in Cash reached 771.47% in 2023, while the deepest fall reached 2926.9% in 2023.
• Calidi Biotherapeutics' Change in Cash stood at $290000.0 in 2022, then slumped by 2926.9% to -$8.2 million in 2023, then surged by 193.85% to $7.7 million in 2024, then plunged by 162.06% to -$4.8 million in 2025.
• Business Quant data shows CLDI's Change in Cash at -$4.8 million in Q4 2025, $5.2 million in Q3 2025, and -$5.4 million in Q2 2025.